Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Publikationen > 2003

Publikationen 2003

Allen M, Barker JWN, Bowcock AM, Burden AD, Chia N, Capon F, Christophers E, Daly MJ, Elder JT, Helms C, Henseler T, Jenisch S, Menter A, Mistry R, Nair RP, Stuart PE, Tillman D, Trembath RC, Veal C, Voorhees JJ; Group Author(s): Int Psoriasis Genetics Consortium
The International Psoriasis Genetics study: Assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs.
Am J Hum Genet 73 : 430-437, 2003

Brandt M, Grotkop C, Steinmann J, Steinhoff G.
Prevention of lung allograft rejecton by combined treatment with adhesion molecule antibodies and cyclosporine.
Interact Cardiovase Thorac Surg 2: 509-513, 2003

Dresske B, Zavazava N, Jenisch S, Exner B, Lenz P, El Mokhtari NE, Kremer B, Faendrich F.
WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.
Transplantation 75: 1286-1291, 2003

Hartung G, Zeis M, Glass B, Dreger P, Steinmann J, Schmitz N, Uharek L.
Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Bone Marrow Transplant 32: 49-56, 2003

Heidebrecht H J, Adam-Klages S, Szczepanowski M, Pollmann M, Buck F, Endl E, Kruse M L, Rudolph P, Parwaresch R.
repp86: A human protein Associated in the progression of mitosis.
Mol Cancer Res 1: 271-279, 2003

Janssen O, Qian J, Kabelitz D.
CD95 ligand - death factor and costimulatory molecule?
Cell Death Differ 10: 1215-1225, 2003

Kabelitz D.
Why not work on T and NK cells in the Kunkel laboratory?
Lupus 12: 195-199, 2003

Kabelitz D.
Significance of gamma/delta T lymphocytes in autoimmune diseases.
Treatment of Autoimmune Disorders. Sticherling M, Christophers E. Springer-Verlag Wien New York 2003

Kabelitz D, Hermeler H.
Potenzial von Stammzellen für die Behandlung von Autoimmunerkrankungen.
Dtsch Ärztebl 100: 28-29, 2003

Kabelitz D, Wesch D.
Features and functions of gamma/delta T lymphocytes: focus on chemokines and their receptors.
Crit Rev Immunol 23: 339-370, 2003

Linkermann A, Qian J, Kabelitz D, Janssen, O.
The Fas ligand as a cell death factor and signal transducer.
Signal Transduction 1-2: 33-46, 2003

Linkermann A, Qian J, Janssen O.
Slowly getting a clue on CD95 ligand biology.
Biochem Pharmacol 66: 1417-1426, 2003

Matthews V, Schuster B, Schütze S, Bussmeyer I, Ludwig A, Hundhausen C, Sadowski T, Saftig P, Hartmann D, Kallen K-J, Rose-John S.
Cellular cholesterol depletion triggers shedding of the human Interleukin-6 receptor by ADAM10 and ADAM17 (TACE).
J Biol Chem 278: 38829-38839, 2003

Siegel S, Wagner A, Kabelitz D, Marget M, Coggin J, Barsoum A, Rohrer J, Schmitz N, Zeis M.
Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematological malignancies.
Blood 102: 4416-4423, 2003

Stritzke J, Zunkel T, Steinmann J, Schmitz N, Uharek L, Zeis M.
Therapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma model.
Br J Haematol 120: 27-35, 2003

Steinmann J, Kabelitz D.
Neue Entwicklungen in der Transplantationsmedizin.
Schleswig-Holst Ärztebl 11: 15-16, 2003

Su Z, Dannull J, Heiser A, Yancey D, Pruitt S, Madden J, Coleman D, Niedzwiecki D, Gilboa E, Vieweg J.
Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.
Cancer Res 63:2127-2133, 2003

Tong Y, Jin J, Yan L, Neppert J, Marget M, Flesch BK.
FCGR3B gene frequencies and FCGR3 variants in a chinese population from Zheijiang province.
Ann Hematol, 82: 574-578, 2003

Triebel T, Grillhösl B, Kacani L, Lell CP, Fuchs A, Speth C, Lass-Flörl C, Steinmann J, Dierich MP, Würzner, R.
Importance of the terminal complement components for immune defence against Candida.
Int J Med Microbiol 292: 527-536, 2003

Wesch D , Kabelitz D.
Differential expression of natural killer receptors on Vdelta1 gamma/delta Tcells in HIV-1-infected individuals.
J Acquir Immune Defic Syndr 33 : 420-425, 2003

Zeis M, Siegel S, Wagner A, Schmitz M, Marget M, Kühl-Burmeister R, Adamzik I, Kabelitz D, Dreger P, Schmitz N, Heiser A.
Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA- transfected dendritic cells.
J Immunol 170: 5391-5397, 2003